Coherus Oncology (CHRS) Non-Current Deferred Revenue (2013 - 2017)
Coherus Oncology's Non-Current Deffered Revenue was $725,000 in Q1 2017, down 97.8% from $32.97 million a year earlier but up 8.4% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Non-Current Deferred Revenue (2013 - 2017) Analysis & Trends
At the end of FY2016, Non-Current Deffered Revenue at Coherus Oncology came in at $669,000, down 98.5% from FY2015.
- Non-Current Deffered Revenue shows a three-year compound annual growth rate of -71.4% (FY2013 to FY2016).
- In earlier years, Non-Current Deffered Revenue was $45.34 million in FY2015 (+13.6%), $39.9 million in FY2014 (+39.7%) and $28.57 million in FY2013.
- Quarterly Non-Current Deffered Revenue has moved between $595,000 (Q3 2016) and $45.34 million (Q4 2015) over five years.
- Compared with a year earlier, Non-Current Deffered Revenue has declined for five straight quarters, with an average decline of 48.4% over the last seven quarters.
- The best year-over-year quarter for Non-Current Deffered Revenue over five years was Q4 2014 (growth of 39.7%); the worst was Q4 2016 (a decline of 98.5%).
- Per Business Quant data, CHRS's Non-Current Deffered Revenue in the three quarters before Q1 2017 was $669,000 (Q4 2016), $595,000 (Q3 2016) and $26.79 million (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.54 Bn | 1,195.15 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 650.21 Bn | 570.07 Bn | 17.30 Bn |
| 3 | AbbVie | 508.24 Bn | 476.24 Bn | 13.12 Bn |
| 4 | Merck | 360.07 Bn | 323.01 Bn | 13.19 Bn |
| 5 | Novartis Ag | 312.26 Bn | 285.49 Bn | - |
| 6 | Astrazeneca | 285.31 Bn | 259.20 Bn | 13.26 Bn |
| 7 | Amgen | 247.74 Bn | 199.39 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.12 Bn | 182.22 Bn | 6.73 Bn |
| 9 | Pfizer | 166.13 Bn | 113.48 Bn | 12.56 Bn |
| 10 | Coherus Oncology | 116.17 Mn | -519.97 Mn | 10.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 725,000.00 |
| Dec 31, 2016 | 669,000.00 |
| Sep 30, 2016 | 595,000.00 |
| Jun 30, 2016 | 26.79 Mn |
| Mar 31, 2016 | 32.97 Mn |
| Dec 31, 2015 | 45.34 Mn |
| Sep 30, 2015 | 33.45 Mn |
| Jun 30, 2015 | 38.49 Mn |
| Mar 31, 2015 | 34.40 Mn |
| Dec 31, 2014 | 39.90 Mn |
| Sep 30, 2014 | 43.53 Mn |
| Dec 31, 2013 | 28.57 Mn |
API Access
Coherus Oncology Non-Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();